SynopsisAdjuvant is an integral part of a vaccine that helps to develop strong immune response in the human body. Conventional vaccines are derived from toxin, inactivated whole organism, and live-attenuated, which are effective in stimulating antibody-based immunity......
Synopsis Due to the COVID-19 pandemic, the global Monitoring Electrodes market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully cons.....
SynopsisThe global Green Laser Photocoagulator market was valued at US$ 86.3 million in 2023 and is anticipated to reach US$ 164 million by 2030, witnessing a CAGR of 9.6% during the forecast period 2024-2030. North American market for Green Laser Photocoagulato.....
SynopsisTDO2 Antibody is an unconjugated antibody to TDO2. The global TDO2 Antibody market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market.....
SynopsisOsteoarthritis Pain Solution is to relieve pain, and cannot slow the progress of osteoarthritis. The global Osteoarthritis Pain Solution market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % duri.....
SynopsisFractional Exhaled Nitric Oxide Detector is a kind of instrument to detect airway inflammation by measuring exhaled nitric oxide content, which has the advantages of non-invasive, safe, quantitative and convenient. The global Fractional Exhaled Nitric Ox.....
SynopsisThe global OTC Topical Skin Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for OTC Topical Skin Medicine is estimated t.....
SynopsisWheeled Examination Lamp so constructed that an intense light is emitted through a slit; used for examination of the eye. The global Wheeled Examination Lamps market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witne.....
SynopsisPegfilgrastim is developed by PEGylating the recombinant human granulocyte colony-stimulating factor (G-CSF) analogue, filgrastim. Pegfilgrastim was first launched by Amgen Inc. as Neulasta in 2002. Later, several biosimilars of pegfilgrastim were launched in .....
SynopsisCRYSVITA is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 6 months of age and older. Market Analysis and Insights: Global Crysvita Market The global Crysvita market was valued at US$ XX in 202.....
